Our CEO, Dr David Ribeiro, will be attending the DxPx Conference, taking place face-to-face in Dusseldorf and in a virtual format, November 12^th – 20^th 2021.

ProAxsis are actively seeking commercial partners for our portfolio of respiratory diagnostics in key territories.  These include:

• Laboratory-based assays for active protease biomarkers associated with chronic respiratory diseases such as cystic fibrosis, bronchiectasis and COPD.
• NEATstik, a qualitative point-of-care test for active neutrophil elastase.
• Our Covid-19 serology test, developed in partnership with AstraZeneca.

If your company has access to pre-existing networks of key respiratory groups, and you’d be interested in exploring any of these exciting opportunities then please contact David to request a meeting via info@proaxsis.com or the DxPx conference partnering system.